Skip to main content

Table 4 ECLS-related complications

From: Therapeutic hypothermia in adult patients receiving extracorporeal life support: early results of a randomized controlled study

Variable

All patients n = 21 (%)

Hypothermia n = 9 (%)

Normothermia n = 12 (%)

P-value

Duration of ECLS (days)

4.4 ± 2.7

4.1 ± 1.8

4.6 ± 3.2

0.675

Bleeding

5 (23.8)

2 (22.2)

3 (25.0)

0.882

Intracranial haemorrhage

1 (4.8)

0 (0)

1 (8.3)

0.375

Intrathoracic or intra-abdominal

3 (14.3)

1 (11.1)

2 (16.7)

0.719

PCT / day of ECLS (units)

2.6 ± 2.0

2.2 ± 1.7

2.9 ± 2.2

0.484

New arrhythmias

4 (19.0)

2 (22.2)

2 (16.7)

0.748

Limb ischaemia

6 (28.6)

2 (22.2)

4 (33.3)

0.577

Distal perfusion cannula

13 (61.9)

6 (66.7)

7 (58.3)

0.697

Acute renal failure

19 (90.5)

8 (88.9)

11 (91.7)

0.830

CRRT

18 (85.7)

7 (77.8)

11 (91.7)

0.368

Pneumonia

7 (33.3)

1 (11.1)

6 (50.0)

0.061

  1. Values for parametric continuous variables are expressed as mean ± standard deviation. Values for categorical variables are expressed as numbers (%)
  2. CRRT continuous renal replacement therapy, ECLS Extracorporeal life support, PCT packed cell transfusion